Objective: Serum folic acid, but not the vitamin B 12 concentration, was found to be significantly lower in obese subjects than in the control ones. Design: The aim of this study was to examine the levels of serum vitamin B 12 and folic acid in obese women before and after weight reduction therapy with Orlistat in comparison to healthy controls with normal body weight. Subjects: Twenty obese women participated in a 3-month weight reduction therapy. The control group consisted of 20 healthy women. Measurements: Body weight and height were measured and BMI was calculated. Body composition was analyzed with the impedance method using a Bodystat analyzer. In all patients before and after 3-month weight reduction therapy, serum concentrations of folic acid and vitamin B 12 were assessed. Obesity is a chronic disorder of multi-factorial etiology, which is known to be one of the well-established risk factors of increased cardiovascular morbidity and mortality. Dietary intervention is the most common treatment of obesity. Orlistat, a selective and potent inhibitor of gastrointestinal lipases involved in triglyceride hydrolysis, which restricts the absorption of triglycerides from GI tract, has become more frequently used in weight reduction programs.
Obesity is a chronic disorder of multi-factorial etiology, which is known to be one of the well-established risk factors of increased cardiovascular morbidity and mortality. Dietary intervention is the most common treatment of obesity. Orlistat, a selective and potent inhibitor of gastrointestinal lipases involved in triglyceride hydrolysis, which restricts the absorption of triglycerides from GI tract, has become more frequently used in weight reduction programs.
Orlistat can potentially reduce vitamin D absorption and decrease its serum concentration. This drug may also change the intestinal flora important for the metabolism of vitamin B12 and folic acid. However, there are no studies evaluating the influence of orlistat on the absorption of vitamins that are produced in GI tract. Low concentrations of vitamins (fat-soluble antioxidants and B vitamins) are linked to accelerated atherosclerosis through increased oxidative stress and homocysteine level.
1 Serum folic acid, but not the vitamin B 12 , concentration was found to be statistically significantly lower in the overweight and obese than in the healthy subjects. 2 The aim of our study was to investigate the levels of serum vitamin B 12 and folic acid in obese women before and after weight reduction therapy with orlistat in comparison to healthy controls with normal body weight. In total, 20 obese women (BMI 37.173.0 kg/m 2 , mean age 49.874.6 years) were diagnosed as having simple obesity without concomitant diseases. All subjects were informed about the nature of this study. The exclusion criteria included evidence of present or recent (preceding 3 months) infectious disease, anemia, drug therapy, smoking cigarettes and drinking more than two drinks a week.
All patients participated in a 3-month weight reduction therapy that consisted of a 1000-1200 kcal/day balanced diet without vitamin supplementation, Orlistat 3 Â 120 mg a day, and regular physical exercises.
Clinical and laboratory measurements were performed at baseline and after the 3-month program. Body weight and height were assessed and BMI was calculated. Body composition was analyzed with the impedance method using a Bodystat analyzer. In all patients before and after 3-month weight reduction therapy, serum concentrations of folic acid and vitamin B 12 (RIA) were assessed.
The control group consisted of 20 healthy women (mean age 53.575.4 years, BMI 24.172.2 kg/m 2 ). Blood samples were taken from each subject in the morning between 0800 and 0900 h, after an overnight fast. After clot formation, the samples were centrifuged (1000 g) at room temperature for 10 min. The serum obtained was drawn into plastic vials and stored at À801C until the time of the assay.
All text and table values are expressed as means7s.d. All analyses were performed using computer program STATISTICA. The results were analyzed using Kołmogorow-Smirnoff test and Spearman's correlation analysis. P-values o0.05 were considered to be statistically significant.
After a 3-month weight reduction program using Orlistat,, the mean weight loss was 11.675.1 kg, which is 12.174.78%. BMI decreased from 37.173.0 kg/m 2 at baseline to 32.672.7 kg/m 2 post-treatment (Table 1) . Serum concentrations of vitamin B 12 and folic acid did not change significantly after therapy (Table 2 ). There were no statistically significant correlations between vitamin B 12 /folic acid and age, weight and body fat (%) both before and after weight reduction therapy.
So far, no differences have been found in serum vitamin B 12 in the overweight and obese subjects compared to the lean ones. In our study after a 3-month therapy, we did not observe significant differences in serum levels of vitamin B 12 and folic acid in obese subjects. We also did not observe any correlations between vitamin B levels and age, weight, and content of body fat (%). It is important to stress that, in the preliminary report, Czerwiñska et al. 5 observed increased serum vitamin B 12 and folic acid concentrations after a 4-month weight reduction therapy using Orlistat. The authors speculated that increased serum vitamin levels were due to changes in intestinal flora during the Orlistat therapy. We did not find any information in the literature about the influence of Orlistat on the growth of intestinal flora that is responsible for vitamin B production. The differences may result from different diet, calories intake (1200 vs 1500 kcal), length of observation (12 vs 16 weeks), amount of subjects (20 vs 13) or individual variability in comparable studies. In fact, none of these factors mentioned above give satisfactory explanation. This issue needs further investigation. We conclude that the 3-month weight reduction therapy with Orlistat does not influence serum levels of vitamin B12 and folic acid in obese women. 3-month weight reduction therapy with Orlistat M Holecki et al
